Newspaper Advertisement of Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2026 is attached herewith.
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gufic Biosciences published its audited financial results for Q4 and FY2026 in newspapers (Business Standard and Mumbai Lakshadeep) on May 30, 2026, as required under SEBI Listing Regulations. The company reported standalone total income of Rs. 33,579.06 lakh for Q4 and Rs. 135,431.61 lakh for the full year FY2026. Net profit after tax for Q4 standalone stood at Rs. 1,322.45 lakh compared to Rs. 1,782.60 lakh in Q4 FY2025. For the full year, standalone net profit was Rs. 3,443.54 lakh versus Rs. 5,362.99 lakh in FY2025, indicating a decline in annual profitability. The consolidated results showed total income of Rs. 166,983.16 lakh for FY2026. The results were reviewed by the Audit Committee and approved by the Board on May 29, 2026.
The year-on-year decline in standalone net profit (down ~36% from FY2025) may concern investors, though the quarterly performance showed improvement from the previous quarter. The filing confirms timely disclosure compliance.